Invention Grant
- Patent Title: Use of megestrol acetate for improving heart function and the treatment of heart insufficiency
- Patent Title (中): 使用醋酸甲地孕酮改善心脏功能和治疗心功能不全
-
Application No.: US11667899Application Date: 2005-12-01
-
Publication No.: US08383612B2Publication Date: 2013-02-26
- Inventor: Stefan Anker
- Applicant: Stefan Anker
- Applicant Address: US NY Spring Valley
- Assignee: Par Pharmaceuticals, Inc.
- Current Assignee: Par Pharmaceuticals, Inc.
- Current Assignee Address: US NY Spring Valley
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP04028474 20041201
- International Application: PCT/EP2005/012843 WO 20051201
- International Announcement: WO2006/058748 WO 20060608
- Main IPC: A01N45/00
- IPC: A01N45/00 ; A61K31/56

Abstract:
The present invention relates to improving the heart function, the survival and/or the treatment of heart insufficiency using megestrol acetate (Megace®; MA) in patients with heart insufficiency and after a myocardial infarction.
Public/Granted literature
- US20080139521A1 Use of Megestrol Acetate for Improving Heart Function and the Treatment of Heart Insufficiency Public/Granted day:2008-06-12
Information query